What should a Positron Emission Tomography (PET) scan show in a patient with Twin Reverse Arterial Perfusion (TRAP) syndrome?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 28, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

PET Scan Findings in TRAP Syndrome

In patients with Twin Reversed Arterial Perfusion (TRAP) syndrome, PET scans are not routinely indicated as ultrasound is the primary imaging modality for diagnosis and monitoring.

Understanding TRAP Syndrome

TRAP sequence is a rare complication unique to monochorionic twin pregnancies, occurring in approximately 1 in 30,000 pregnancies and in 0.3% of all monozygotic twin gestations 1. The condition is characterized by:

  • A structurally normal "pump" twin
  • An acardiac "parasitic" twin without cardiac activity
  • Reversed arterial perfusion via anomalous arterio-arterial placental anastomoses

Primary Imaging Modality for TRAP Syndrome

Ultrasound

  • Transabdominal ultrasound is the primary and most appropriate imaging modality for diagnosis and monitoring of TRAP syndrome 1
  • Key ultrasound findings include:
    • Structurally normal pump twin
    • Acardiac twin with reversed flow in its umbilical artery
    • Markedly anomalous acardiac twin (often acephalic, lacking upper extremities, with marked edema)
    • Arterio-arterial placental anastomoses

Monitoring Parameters on Ultrasound

  • Volume/weight of the acardiac twin should be calculated at each imaging session 1
  • Ratio of acardiac twin weight to pump twin weight (critical threshold >50%)
  • Signs of cardiac decompensation in the pump twin 1
  • Doppler assessment of umbilical artery and middle cerebral artery of the pump twin

Role of PET Scanning in TRAP Syndrome

PET scanning has no established role in the diagnosis or management of TRAP syndrome. The American College of Radiology guidelines do not mention PET scanning for TRAP syndrome evaluation 1.

Other Imaging Modalities in TRAP Syndrome

MRI

  • May provide additional anatomical detail of the acardiac twin 2
  • Can help visualize the vascular connections between twins
  • Not routinely required unless ultrasound findings are equivocal

3D and Color Doppler Ultrasound

  • Adds value for both diagnosis and detection of poor prognostic features 3
  • Helps visualize the reversed arterial flow pattern

Management Considerations

The primary concern in TRAP syndrome is the high mortality rate (approximately 50%) of the pump twin due to cardiac overload 1. Intervention is indicated when:

  • The estimated weight of the acardiac twin is ≥50% of the pump twin
  • Features of cardiac decompensation are seen in the pump twin
  • Treatment involves interruption of flow in the communicating vessels or umbilical cord of the anomalous twin

Conclusion

While PET scanning has important applications in other conditions such as prosthetic heart valve endocarditis 1, 4, it has no established role in TRAP syndrome diagnosis or management. Ultrasound remains the gold standard imaging modality for this rare condition, with MRI serving as a complementary imaging technique when additional anatomical detail is needed.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Twin reversed arterial perfusion sequence: a rare entity.

Journal of clinical imaging science, 2015

Research

Detection of twin reversed arterial perfusion sequence at the time of first-trimester screening: the added value of 3-dimensional volume and color Doppler sonography.

Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine, 2008

Guideline

PET/CT Imaging in Oncology and Beyond

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.